Intellectual Property India Publishes Patent Application for 'Synthesis Of Substituted 1 Aryl 1 Heteroaryl Compounds And Substituted 1 1 Biheteroaryl Compounds And Analogues Thereof' Filed by Arbutus Biopharma Corporation

MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517020675 A) filed by Arbutus Biopharma Corporation, Vancouver, Canada, on March 7, for 'synthesis of substituted 1 aryl 1 heteroaryl compounds and substituted 1 1 biheteroaryl compounds and analogues thereof.'

Inventor(s) include Cole Andrew G.; Mason Jeremy; Nguyen Duyan; Ozturk Seyma; Pallerla Mahesh Kumar; Pamulapati Ganapati Reddy; and Spink Jan Michelle.

The application for the patent was published on June 6, under issue no. 23/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure includes synthetic methods for preparing certain substituted 1 aryl 1 heteroaryl and 1 1 biheteroaryl compounds which can be used to treat ameliorate and/or prevent hepatitis B virus (HBV) infections in a patient in particular compound 2 ((6 (2 chloro 3 (3 chloro 2 (3 methoxy 4 ((7 oxo 2 6 diazaspiro[3.4]octan 2yl)methyl)phenyl)pyridin 4 yl)phenyl) 2 methoxypyridin 3 yl)methyl) 2 6 diazaspiro[3.4]octan 7 one."

The patent application was internationally filed on Aug. 09, 2023, under International application No.PCT/IB2023/058055.

Disclaimer: Curated by HT Syndication.